Document Detail


Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.
MedLine Citation:
PMID:  20972337     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Many common disorders of pregnancy are attributed to insufficient invasion of the uterine lining by trophoblast, fetal cells that are the major cell type of the placenta. Interactions between fetal trophoblast and maternal uterine NK (uNK) cells--specifically interactions between HLA-C molecules expressed by the fetal trophoblast cells and killer Ig-like receptors (KIRs) on the maternal uNK cells--influence placentation in human pregnancy. Consistent with this, pregnancies are at increased risk of preeclampsia in mothers homozygous for KIR haplotype A (KIR AA). In this study, we have demonstrated that trophoblast expresses both paternally and maternally inherited HLA-C surface proteins and that maternal KIR AA frequencies are increased in affected pregnancies only when the fetus has more group 2 HLA-C genes (C2) than the mother. These data raise the possibility that there is a deleterious allogeneic effect stemming from paternal C2. We found that this effect also occurred in other pregnancy disorders (fetal growth restriction and recurrent miscarriage), indicating a role early in gestation for these receptor/ligand pairs in the pathogenesis of reproductive failure. Notably, pregnancy disorders were less frequent in mothers that possessed the telomeric end of the KIR B haplotype, which contains activating KIR2DS1. In addition, uNK cells expressed KIR2DS1, which bound specifically to C2+ trophoblast cells. These findings highlight the complexity and central importance of specific combinations of activating KIR and HLA-C in maternal-fetal immune interactions that determine reproductive success.
Authors:
Susan E Hiby; Richard Apps; Andrew M Sharkey; Lydia E Farrell; Lucy Gardner; Arend Mulder; Frans H Claas; James J Walker; Christopher W Redman; Christopher C Redman; Linda Morgan; Clare Tower; Lesley Regan; Gudrun E Moore; Mary Carrington; Ashley Moffett
Related Documents :
12606367 - Osteopontin is synthesized by uterine glands and a 45-kda cleavage fragment is localize...
18089607 - Vascular remodeling and extracellular matrix breakdown in the uterine spiral arteries d...
20338637 - Secretion of angiogenic growth factors by villous cytotrophoblast and extravillous trop...
9619567 - Characteristic changes of large granular lymphocytes that strongly express cd56 in endo...
11832787 - Focus on primary care: from nevus to neoplasm: myths of melanoma in pregnancy.
12887287 - Circulating levels of ghrelin in human fetuses.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-10-25
Journal Detail:
Title:  The Journal of clinical investigation     Volume:  120     ISSN:  1558-8238     ISO Abbreviation:  J. Clin. Invest.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-02     Completed Date:  2010-12-07     Revised Date:  2012-02-07    
Medline Journal Info:
Nlm Unique ID:  7802877     Medline TA:  J Clin Invest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4102-10     Citation Subset:  AIM; IM    
Affiliation:
Department of Pathology, University of Cambridge, Cambridge, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortion, Habitual / immunology*
Animals
Female
Fetus* / immunology,  physiology
Genotype
HLA-C Antigens* / genetics,  immunology
Haplotypes
Humans
Killer Cells, Natural / immunology
Male
Maternal-Fetal Relations
Placentation / immunology*,  physiology
Pre-Eclampsia / immunology
Pregnancy / immunology*
Pregnancy Complications / genetics,  immunology
Protein Isoforms / genetics,  metabolism*
Receptors, KIR / genetics,  metabolism*
Trophoblasts / immunology
Grant Support
ID/Acronym/Agency:
HHSN261200800001E//PHS HHS; //British Heart Foundation; //Wellcome Trust
Chemical
Reg. No./Substance:
0/HLA-C Antigens; 0/Protein Isoforms; 0/Receptors, KIR
Comments/Corrections
Comment In:
J Clin Invest. 2010 Nov;120(11):3801-4   [PMID:  20972330 ]
Erratum In:
J Clin Invest. 2011 Jan 4;121(1):455
Note: Redman, Christopher C [corrected to Redman, Christopher W]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Infusion of mature megakaryocytes into mice yields functional platelets.
Next Document:  Identifying patient fear-avoidance beliefs by physical therapists managing patients with low back pa...